Enanta Pharmaceuticals In... (ENTA)
NASDAQ: ENTA
· Real-Time Price · USD
5.29
-0.03 (-0.56%)
At close: May 09, 2025, 3:59 PM
5.27
-0.47%
After-hours: May 09, 2025, 04:05 PM EDT
-0.56% (1D)
| Bid | 5.15 |
| Market Cap | 112.96M |
| Revenue (ttm) | 66.59M |
| Net Income (ttm) | -104.93M |
| EPS (ttm) | -4.95 |
| PE Ratio (ttm) | -1.07 |
| Forward PE | -1.18 |
| Analyst | Buy |
| Ask | 5.46 |
| Volume | 62,283 |
| Avg. Volume (20D) | 328,824 |
| Open | 5.31 |
| Previous Close | 5.32 |
| Day's Range | 5.25 - 5.48 |
| 52-Week Range | 4.09 - 17.23 |
| Beta | 0.82 |
About ENTA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENTA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Enanta Pharmaceuticals Inc. is scheduled to release its earnings on May 20, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+14.08%
Enanta Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
5 months ago
+11.75%
Enanta Pharmaceuticals shares are trading higher after the company announced topeline results from its first-in-pediatrics Phase 2 study evaluating Zelicapavir for children aged 28 days to 36 months with respiratory syncytial vrius.
